Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Blood Reviews|January 5, 2024
Αlpha-thalassemia: A practical overviewKhaled M Musallam, M Domenica Cappellini, Thomas D Coates, et al.
Clinical and Translational Science|December 19, 2025
Pharmacogenomic and Clinical Predictors of Deferasirox Response in Transfusion-Dependent Thalassemia Identified Using Whole-Genome SequencingKittika Yampayon, Watchara Sakares, Krittin Pitinanon, et al.
The Analyst|January 29, 2025
Bioanalytical method for NAD+ detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detectionWichit Taron, Tharinda Kasemphong, Pachanuporn Sunon, et al.
European Journal of Haematology|June 9, 2004
Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorderVip Viprakasit, Prin Vathesathokit, Worrawut Chinchang, et al.
American Journal of Hematology|March 6, 2013
Deferiprone (GPO-L-ONE(®) ) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from ThailandVip Viprakasit, Issarang Nuchprayoon, Ampaiwan Chuansumrit, et al.
Haematologica|December 22, 2010
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overloadHugh Young Rienhoff, Vip Viprakasit, Lay Tay, et al.
European Journal of Haematology|November 25, 2014
Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA studyYesim Aydinok, John B Porter, Antonio Piga, et al.
Blood Cells, Molecules & Diseases|May 10, 2003
Hemochromatosis gene (HFE) mutations in South East Asia: a potential for iron overloadJennifer J Pointon, Vip Viprakasit, Katie L Miles, et al.
European Journal of Haematology|January 28, 2014
Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasiroxAli T Taher, John B Porter, Vip Viprakasit, et al.
O&G Open|July 6, 2026
Addressing Obstetric and Gynecologic Needs in ThalassemiaEvangelia Vlachodimitropoulou, Marina Baldini, Hanny Al-Samkari, et al.
Pageof 16